Exclusion of Older Adults from Ongoing Clinical Trials About Type 2 Diabetes Mellitus
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Objective: To assess the extent of exclusion of older individuals from ongoing clinical trials regarding type 2 diabetes mellitus. Design: Cohort study. Setting: W orld H ealth O rganization C linical T rials R egistry P latform. Participants: Using the P articipation of the E lderly in C linical T rials methodology, data from ongoing clinical trials on type 2 diabetes mellitus were extracted from the platform on July 31, 2011. Measurements: Proportion of trials excluding individuals using an arbitrary upper age limit or other exclusion criteria that might indirectly cause limited recruitment of older individuals. Exclusion criteria were classified as justified or poorly justified. Results: Of 440 trials investigating treatments for type 2 diabetes mellitus, 289 (65.7%) excluded individuals using an arbitrary upper age limit. Such exclusion was significantly more common in trials with calculated sample sizes of less than 100 subjects (73.6% vs 59.5%; P = .002). Exclusion for comorbidity was present in 338 trials (76.8%); this exclusion was poorly justified in 236 trials (53.6%). Exclusion for polypharmacy (29.5% of trials), cognitive impairment (18.4%), short life expectancy (8.9%), and other poorly justified exclusion criteria that could limit the inclusion of older individuals was also present. Only six trials (1.4%) were designed specifically to study older adults. Conclusion: Despite the recommendations of international regulatory agencies, exclusion of older individuals from ongoing trials regarding type 2 diabetes mellitus is frequent—higher than reported for other age‐related diseases. This exclusion limits the value of the evidence that clinicians use when treating old, frail, complex patients with diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cowie, C. C., Rust, K. F., Byrd-Holt, D. D., Gregg, E. W., Ford, E. S., Geiss, L. S., Bainbridge, K. E., & Fradkin, J. E. (2010) · Diabetes Care · doi:10.2337/dc09-1524 · Cited by 689
Guidelines for improving the care of the older person with diabetes mellitus
California Healthcare Foundation/American Geriatrics Society, C. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.51.5s.1.x · Cited by 651
The Exclusion of the Elderly and Women From Clinical Trials in Acute Myocardial Infarction
Gurwitz, J. H. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490110055029 · Cited by 532 · cited 1×
“Specialist journals on diabetes mellitus do not seem to be interested in the mismatch between research populations and populations in clinical practice, something that journals devoted to cardiovascular medicine have been looking at for more than 20 years.(16) Table 2.”
BackgroundSinclair, A., Morley, J. E., Rodriguez-Mañas, L., Paolisso, G., Bayer, T., Zeyfang, A., Bourdel-Marchasson, I., Vischer, U., Woo, J., Chapman, I., et al. (2012) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2012.04.012 · Cited by 422 · cited 1×
“Despite the importance of diabetes mellitus, research on the management of older individuals with diabetes mellitus, who may have high levels of morbidity, use multiple therapies, and have physical and mental impairments, is sparse, and evidence of a sound individualized decision-making process is lacking.(4) The few…”
BackgroundSinclair, A. J., Paolisso, G., Castro, M., Bourdel-Marchasson, I., Gadsby, R., & Rodriguez Mañas, L. (2011) · Diabetes & Metabolism · doi:10.1016/s1262-3636(11)70962-4 · Cited by 298
Bayer, A. (2000) · BMJ · doi:10.1136/bmj.321.7267.992 · Cited by 175 · cited 2×
“Thus, age limits are arbitrary, change over time, and are not explained in study protocols.(11,17) Abolishing age limits and reducing other exclusion criteria should improve the representation of older people in clinical research and ensure that the evidence base is relevant and useful to all those caring for older pe…”
Background
Cited by
Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes
Lipska, K. J., Krumholz, H., Soones, T., & Lee, S. J. (2016) · JAMA · doi:10.1001/jama.2016.0299 · Cited by 309
Swift, H. J., Abrams, D., Lamont, R. A., & Drury, L. (2017) · Social Issues and Policy Review · doi:10.1111/sipr.12031 · Cited by 289
Lee, A. K., Warren, B., Lee, C. J., McEvoy, J. W., Matsushita, K., Huang, E. S., Sharrett, A. R., Coresh, J., & Selvin, E. (2018) · Diabetes Care · doi:10.2337/dc17-1669 · Cited by 226
“Much of the epidemiologic evidence on this topic comes from secondary analyses of randomized clinical trials, which often recruit high-risk populations that are less representative of the general population (16).”
Diabetes and Aging: unique considerations and goals of care
Kalyani, R. R., Golden, S. H., & Cefalu, W. T. (2017) · Diabetes Care · doi:10.2337/dci17-0005 · Cited by 226
“older adults continue to be excluded from two-thirds of these trials (13), further hindering the ability to generalize ongoing trial results to the older population with diabetes.”
BackgroundUnderrepresentation of the Elderly in Clinical Trials, Time for Action
van Marum, R. J. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14539 · Cited by 159
“Clinical Trials Registry Platform for ongoing clinical trials about type 2 diabetes mellitus.(11) Of 440 eligible trials, 65.”
Method
Metadata
- Authors
- Cruz‐Jentoft, A. J., Carpena‐Ruiz, M., Montero‐Errasquín, B., Sánchez‐Castellano, C., & Sánchez‐García, E.
- Venue
- Journal of the American Geriatrics Society
- Publisher
- Wiley
- Published
- 2013-04-16
- Volume
- 61
- Issue
- 5
- Pages
- 734-738
- ISSN
- 0002-8614 (ISSN-L)
- 1532-5415
- OpenAlex
- W2043557820
- Cited by
- 133
- References
- 6
- FWCI
- 8.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exclusion of Older Adults from Ongoing Clinical Trials About Type 2 Diabetes Mellitus. https://app.cochat.ai/papers/10.1111/jgs.12215
- The paper
- Cruz‐Jentoft, A. J., Carpena‐Ruiz, M., Montero‐Errasquín, B., Sánchez‐Castellano, C., & Sánchez‐García, E. (2013). Exclusion of Older Adults from Ongoing Clinical Trials About Type 2 Diabetes Mellitus. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.12215
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.